What they were paid
Enfusion Director Compensation Table · all 3 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2024 | $185,914 | $472,290 | $0 | $0 | $658,204 |
| FY2023 | $185,914 | $472,290 | — | — | $658,204 |
| FY2022 | $0 | $0 | $0 | $0 | $0 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Enfusion, Inc. DEF 14A filed April 26, 2024, accession 0001558370-24-005911, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2024Enfusion pays directors a $35,000 cash retainer and $125,000 in equity.
The rest of the Enfusion board
FY2024 · as the company reported each| Director | Role | FY2024 total |
|---|---|---|
| Bradford E. Bernstein | Independent Director | $0 |
| Deirdre Somers | Independent Director | $462,871 |
| Jan R. Hauser | Independent Director | $234,671 |
| Kathleen Traynor DeRose | Independent Director | $228,172 |
| Lawrence Leibowitz | Independent Director | — |
| Oleg Movchan | Director | $0 |
| Roy Luo | Independent Director | $0 |
The full Enfusion compensation record
free company briefThis page is one director within Enfusion's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat